Subtotal $0.00
Shop Now
GLP-1 fatigue is a recognized side effect, though less common than nausea or constipation. In the U.S. prescribing information, 11% of adults taking Wegovy injection for weight management reported fatigue or weakness versus 5% on placebo, and 5% to 7% of adults on Zepbound reported it versus 3%. The labels do not explain why it happens. Likely contributors include eating far less than before, fluid loss from digestive side effects, low blood sugar in people who also take insulin or a sulfonylurea, and nutrient gaps. Tiredness can also come from causes unrelated to the medicine, such as anemia, thyroid problems or poor sleep, so fatigue that is severe or lasts is worth raising with a clinician.
Peptide Labs does not sell Ozempic, Wegovy, Mounjaro, Zepbound or any prescription drug. This article summarizes FDA labels and published research. For every effect listed across the class, see our guide to GLP-1 medicine side effects.
Key Takeaways
- Fatigue affected 11% on Wegovy versus 5% on placebo, and 5% to 7% on Zepbound versus 3%.
- The Wegovy, Zepbound and Foundayo Medication Guides list tiredness among the most common side effects.
- In one trial, people on semaglutide ate 35% less at a free-choice lunch than people on placebo.
- Low blood sugar, which can cause weakness and drowsiness, is mainly a risk with insulin or sulfonylureas.
- Regular meals with protein, steady fluids, strength training and sleep are sensible first steps.
- Fatigue with confusion, dizziness, fever or unexplained weight loss needs a clinician.
How common is GLP-1 fatigue? Label rates by drug
Each label counts fatigue a little differently. The Wegovy figure combines fatigue and asthenia (weakness), while the Zepbound figure combines asthenia, fatigue, lethargy and malaise. Ranges span the maintenance strengths, and the trials enrolled different people for different lengths of time, so read the numbers as context rather than a ranking.
| Drug (approved use) | Fatigue: drug vs placebo | Label revision |
|---|---|---|
| Wegovy injection (weight management) | 11% vs 5% | June 2026 |
| Zepbound (weight management) | 5% to 7% vs 3% | August 2026 |
| Foundayo tablets (weight management) | 6% to 9% vs 4% | July 2026 |
| Ozempic injection (type 2 diabetes) | Listed among other reactions above 0.4%, no placebo rate | May 2026 |
| Mounjaro (type 2 diabetes) | 10% in a heart outcomes trial against dulaglutide; not in the placebo table | August 2026 |
The pattern resembles the digestive side effects: products used for weight management, at higher strengths and often in people without diabetes, report more tiredness than the diabetes versions. Placebo groups also report some fatigue (3% to 5%), a reminder that eating less and changing routines can be tiring on its own. The Wegovy label adds that common side effects with Wegovy tablets were similar in type and frequency to those with the injection.
Zepbound fatigue and Ozempic fatigue in the Medication Guides
Zepbound fatigue appears in plain words in the patient Medication Guide, which lists “feeling tired” among the most common side effects, alongside nausea, diarrhea, vomiting and constipation. The Foundayo guide uses the same words, and the Wegovy guide lists “tiredness (fatigue)”. Ozempic fatigue is less prominent: the Ozempic prescribing information names fatigue, a change in taste (dysgeusia) and dizziness as other reactions seen in more than 0.4% of people, without a placebo comparison. Our guides to Zepbound and semaglutide cover the rest of each label.
None of the labels reports how long fatigue tends to last. For digestive effects, the Zepbound label says nausea, vomiting and diarrhea mostly occurred while the strength was being increased and decreased over time. Whether tiredness follows the same course has not been studied in the same detail.
Why am I so tired on Ozempic? Possible contributors
If you are wondering “why am I so tired on Ozempic?”, the honest answer is that the labels list fatigue without giving a cause. The factors below are plausible contributors drawn from the labels and from a 2025 nutrition advisory. None has been proven to be the main driver, and more than one can apply at the same time.
Eating much less than before
GLP-1 medicines reduce appetite strongly. In a 20-week trial of 72 adults with obesity, published in Diabetes, Obesity and Metabolism in 2021, people on semaglutide ate 35% less energy at a free-choice lunch than those on placebo; Novo Nordisk funded the study. A 2025 joint advisory from four U.S. obesity, nutrition and lifestyle-medicine societies notes calorie reductions of 16% to 39% with these drugs and warns that intake of several nutrients can fall too. Skipping meals because you are not hungry can leave long stretches without food. Our article on why hunger signals change explains the appetite hormones these medicines act on.
Fluid loss and dizziness
Nausea, vomiting and diarrhea can lead to dehydration. Every GLP-1 label in this article carries a warning about acute kidney injury in people who became dehydrated after digestive side effects, and the Medication Guides advise drinking fluids. Feeling light-headed often travels with low energy: dizziness was reported by 8% on Wegovy versus 4% on placebo and by 4% to 5% on Zepbound versus 2%, and the Zepbound label lists low blood pressure in 1% to 2% versus 0% on placebo.
Low blood sugar
The labels say the risk of hypoglycemia rises when a GLP-1 medicine is combined with insulin or a sulfonylurea. Signs listed in the Medication Guides include weakness, confusion or drowsiness, dizziness, sweating, shakiness, hunger and a fast heartbeat. Low blood sugar has also been reported in adults without type 2 diabetes, although the Wegovy weight trials did not systematically measure it, and the Wegovy label notes more serious episodes in people with a history of bariatric surgery.
Nutrient gaps, including B12
The 2025 advisory lists nutrients to watch during GLP-1 therapy, including iron, magnesium and vitamins D and B12, and says clinicians may suggest a supplement such as a multivitamin. Low iron and low B12 can both cause tiredness. Many people with type 2 diabetes also take metformin, and the American Diabetes Association notes that metformin use is linked with a higher risk of B12 deficiency and suggests periodic testing. Our guides to vitamin B12 and metformin explain who is most at risk.
Sleep, mood and other causes
MedlinePlus lists common causes of fatigue that have nothing to do with a new medicine: anemia, an underactive or overactive thyroid, sleep disorders such as obstructive sleep apnea, depression or grief, and medicines such as sedatives or antidepressants. Sleep apnea is common in people with obesity, and in December 2024 the FDA approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity. Daytime sleepiness is worth mentioning to your prescriber rather than assuming it is a drug effect.
Habits that may help with energy on a GLP-1 medicine
No trial has tested ways to reduce fatigue on these drugs specifically. The habits below come from the 2025 advisory, the Medication Guides and the general fatigue advice from MedlinePlus.
- Eat regular small meals with protein. The advisory favors regular small meals over long gaps or large meals, with an emphasis on protein and minimally processed foods. Our eating guide for GLP-1 medicines has practical meal ideas.
- Drink fluids through the day. Sipping steadily is easier than large drinks when you feel full, and it matters more if you have vomiting or diarrhea.
- Keep up strength training. Part of the weight lost on these drugs is lean mass, and the advisory recommends resistance exercise alongside aerobic activity to help preserve muscle.
- Protect your sleep. MedlinePlus lists enough sleep, regular exercise, relaxation and stress management as self-care steps for fatigue.
- Go easy on alcohol. It can add to stomach upset and dehydration; see our guide to GLP-1 drugs and alcohol.
- Check before adding supplements. Ask a pharmacist or prescriber first, especially if you take insulin, a sulfonylurea or metformin.
If digestive symptoms are part of the picture, our guides to Ozempic nausea and Ozempic constipation cover what the labels and expert panels suggest. Tell your prescriber if fatigue is hard to live with; they can review your other medicines and whether the pace of strength increases suits you.
When tiredness on a GLP-1 drug needs a clinician
MedlinePlus advises contacting a provider right away for confusion or dizziness, blurred vision or thoughts of suicide, and making an appointment for unexplained weakness or fatigue, especially with fever, unintentional weight loss or regular sweats. On a GLP-1 medicine, also call your prescriber promptly if:
- You take insulin or a sulfonylurea and notice shakiness, sweating, confusion, drowsiness or weakness, which can signal low blood sugar.
- Nausea, vomiting or diarrhea will not go away and you feel weak or dizzy, possible signs of dehydration.
- Tiredness is severe, keeps getting worse or stops you from managing daily tasks.
- You also have severe stomach pain that will not go away, which the Medication Guides link to pancreatitis or gallbladder problems.
Deciding which blood tests make sense, for example for anemia, thyroid function or B12, is a job for your clinician, who knows your history and other medicines. Note how long the tiredness has lasted and whether it started after a change in strength. Do not stop the medicine on your own; the Wegovy label notes semaglutide stays in the body for about 5 to 7 weeks after the last weekly injection, so stopping does not bring quick relief.
Frequently Asked Questions
Is fatigue a common side effect of GLP-1 drugs?
It is listed but less common than digestive effects. Fatigue affected 11% on Wegovy versus 5% on placebo, 5% to 7% on Zepbound versus 3%, and 6% to 9% on Foundayo versus 4%.
Why am I so tired on Ozempic?
The label does not give a cause. Eating much less, fluid loss from digestive side effects, low blood sugar with insulin or sulfonylureas, nutrient gaps and unrelated causes such as poor sleep or anemia can all contribute.
Does Zepbound fatigue go away?
The label does not report how long fatigue lasts. Digestive effects tend to ease after the step-up period, but tiredness that persists or worsens should be discussed with your prescriber.
Can low B12 cause tiredness on a GLP-1 medicine?
Low B12 can cause tiredness, and long-term metformin use raises the risk of deficiency. The American Diabetes Association suggests periodic B12 testing for people taking metformin.
Should I take an energy supplement for GLP-1 fatigue?
No supplement has been shown to relieve fatigue on these drugs. Stimulant products can disturb sleep and raise heart rate, and the Wegovy label already advises monitoring heart rate. Ask a pharmacist or prescriber first.
When should I see a doctor about tiredness on Wegovy?
Right away for confusion, dizziness or blurred vision; soon for unexplained fatigue with fever, unintentional weight loss or sweats, or any tiredness that is severe or getting worse.
Peptide Labs does not sell GLP-1 medicines or any prescription drug. This article is general information, not medical advice. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed October 2026.
Related guides: GLP-1 Side Effects: What Every GLP-1 Drug Label Warns About, GLP-1 Diet: What Experts Recommend While on GLP-1 Medicines, B12 Benefits: What Vitamin B12 Does, Who Runs Low and Which Form, Ozempic Muscle Loss: What the Body-Scan Data Show, Ozempic Headache: Label Rates, Causes and Warning Signs.